Q4 2018 Anika Therapeutics Earnings Conference Call | Anika Therapeutics, Inc.

Skip to main navigation

About Us
Products
- Overview
- Orthobiologics
  - ORTHOVISC
  - ORTHOVISC MINI
  - MONOVISC
  - CINGAL
  - ORTHOVISC-T
  - TACTOSET
  - HYALOFAST
  - HYALONECT
  - HYALOGLIDE
- Dermal
- Surgical
- Other HA Solutions
  - ANIKAVISC
  - HYVISC
Technology
Investor Relations
Careers

Search

Investor Relations

Tools

Print
Share

Shareholder Tools

Information Request
Email Alerts
IR Contacts
Virtual Investor Kit
Q2 2020 Fact Sheet
RSS Feeds

Volume:

on

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Facebook
LinkedIn
Twitter
RSS

Investor Relations

Corporate Overview
Corporate Governance
Stock Information
Analyst Coverage
SEC Filings
Annual Reports and Proxies
Quarterly Results
News Releases
Events & Presentations
Investor FAQs

Q4 2018 Anika Therapeutics Earnings Conference Call

Feb 21, 2019 5:00 PM EST

Listen to webcast

View Presentation 591.5 KB

© 2020 Anika Therapeutics, Inc. All rights reserved.

Privacy Policy
Site Map
Terms of Use
Forward Looking Statements
Supplier Information

This website uses cookies to improve user experience and track anonymous site usage. Click here to read more about how we use cookies.